“We received incredible support from our retailer community,” said Amy Mirialakis, director of sales at Nordic Naturals. “We ...

Paris, France (17 octobre 2024 – 18h00) – EssilorLuxottica annonce que son chiffre d’affaires consolidé du troisième trimestre 2024 s'élève à 6 437 millions d’euros, en hausse de 4,0 % à taux de ...

Solera Health, a unique technology platform for connecting people seamlessly and easily to digital health solutions that work, today announced the results of a first-of-its-kind study estimating the ...

Following natural disasters, access to clean, safe water is paramount for healthcare facilities, where contaminated water may severely compromise patient care and operations. The deployment of Nephros ...

“The IMF is thrilled to congratulate Dr. Chen on receiving the prestigious AMN Distinguished Service Award. Dr. Chen's exceptional contributions to the field of myeloma research, clinical trials, and ...

growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating the indicator for the financial year in qu ...

This study investigates the use of Oxford Nanopore sequencing on circulating cell-free DNA (cfDNA) derived from blood plasma to detect key copy number alterations (CNAs) in lung cancer patients. CNAs ...

ISELIN, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom ...

Paris, France (October 17, 2024 - 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the third quarter of 2024 reached Euro 6,437 million, representing a year-on-year increase ...

As an industry leader advancing payment integrity, WellRithms has nearly doubled its revenue over the past two years. This recognition from BenefitsPro follows WellRithms’ inclusion in Inc. Magazine’s ...

TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination technologies, today announced that its iHP Corporate Service division is expected to ...

NANTES, France, October 17, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be presenting its novel OSE-CYTOMASK Cis-Demasking 1 cytokine technology in ...